Comparison of FACE-Q Score of Different Treatment Groups (a-PRP, HA, and Cellular Matrix) in the Follow-Up
| . | a-PRP vs HA . | a-PRP vs Cellular Matrix . | HA vs Cellular Matrix . |
|---|---|---|---|
| 1 month | 0.005** | <0.0001**** | <0.0001**** |
| 3 months | NS | <0.0001**** | <0.0001**** |
| 6 months | NS | <0.0001**** | <0.0001**** |
| . | a-PRP vs HA . | a-PRP vs Cellular Matrix . | HA vs Cellular Matrix . |
|---|---|---|---|
| 1 month | 0.005** | <0.0001**** | <0.0001**** |
| 3 months | NS | <0.0001**** | <0.0001**** |
| 6 months | NS | <0.0001**** | <0.0001**** |
P, one-tailed t test. a-PRP, autologous platelet-rich plasma; Cellular Matrix, combination of a-PRP and HA; HA, hyaluronic acid; NS, not significant.
****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05.
Comparison of FACE-Q Score of Different Treatment Groups (a-PRP, HA, and Cellular Matrix) in the Follow-Up
| . | a-PRP vs HA . | a-PRP vs Cellular Matrix . | HA vs Cellular Matrix . |
|---|---|---|---|
| 1 month | 0.005** | <0.0001**** | <0.0001**** |
| 3 months | NS | <0.0001**** | <0.0001**** |
| 6 months | NS | <0.0001**** | <0.0001**** |
| . | a-PRP vs HA . | a-PRP vs Cellular Matrix . | HA vs Cellular Matrix . |
|---|---|---|---|
| 1 month | 0.005** | <0.0001**** | <0.0001**** |
| 3 months | NS | <0.0001**** | <0.0001**** |
| 6 months | NS | <0.0001**** | <0.0001**** |
P, one-tailed t test. a-PRP, autologous platelet-rich plasma; Cellular Matrix, combination of a-PRP and HA; HA, hyaluronic acid; NS, not significant.
****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
